A carregar...
Adaptive resistance to RAF inhibitors in melanoma
The discovery of activating mutations in BRAF at high frequency in cutaneous melanoma opened the door to new treatment options, which have resulted in significantly better patient outcomes. Treatments such as the FDA-approved RAF inhibitor vemurafenib, and the more recently approved dabrafenib and t...
Na minha lista:
| Main Authors: | , |
|---|---|
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
2014
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4212018/ https://ncbi.nlm.nih.gov/pubmed/24828387 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/pcmr.12264 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|